LK
Lalit Kumar
About Lalit Kumar
Lalit Kumar has 24 years in corporate governance. Holds Director role. Currently with 2 companies, including Lifeways Formulations Private Limited and Antigen Healthcare Private Limited. Formerly with 2 companies, such as Makmaul Laboratories Private Limited and Cambist Biotech Private Limited. Engaged in General Business, Healthcare and more. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Lifeways Formulations Private Limited
U52310DL2016PTC290357
|
Director | 29 Jan 2016 | 2016 | Active |
Antigen Healthcare Private Limited
U74899DL2002PTC114384
|
Director | 26 Feb 2002 | 2002 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Makmaul Laboratories Private Limited
U00304DL2005PTC140231
|
Director | 31 Aug 2005 | 2005 | Active |
Cambist Biotech Private Limited
U85121DL2006PTC152725
|
Director | 10 Dec 2006 | 2006 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Lalit Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lalit Kumar
Lalit Kumar has 24 years in corporate governance. Holds Director role. Currently with 2 companies, including Lifeways Formulations Private Limited and Antigen Healthcare Private Limited. Formerly with 2 companies, such as Makmaul Laboratories Private Limited and Cambist Biotech Private Limited. Engaged in General Business, Healthcare and more. Contributes to corporate operations.
Lalit Kumar is associated with 2 companies as Director.
Lalit Kumar has expertise in General Business, Healthcare and other sectors.
Lalit Kumar has 24 years in corporate governance.